TheraNovex Launches Uber-Powered Ride Share Technology for Clinical Trial Participants

Revolutionary transportation solution eliminates travel barriers and increases trial participation by 40%

TheraNovex today announced the launch of its groundbreaking ride share technology platform specifically designed for clinical trial participants. This innovative solution partners with leading ride-sharing services to provide seamless, sponsored transportation to and from study visits, eliminating one of the most significant barriers to clinical trial participation.

Addressing Transportation Barriers

Transportation has long been identified as one of the primary obstacles preventing eligible patients from participating in clinical trials. Studies have shown that up to 30% of potential participants cite transportation difficulties as their primary reason for declining trial participation. TheraNovex's new platform directly addresses this challenge by providing a comprehensive, technology-driven solution.

"We recognized that transportation barriers were significantly impacting trial enrollment and participant retention," said Dr. Sarah Chen, Chief Innovation Officer at TheraNovex. "By leveraging existing ride-sharing infrastructure and integrating it seamlessly into the clinical trial process, we've created a solution that benefits participants, research sites, and sponsors alike."

How the Platform Works

The TheraNovex ride share platform integrates directly with clinical trial management systems, allowing research coordinators to:

• Schedule rides automatically when study visits are booked
• Monitor participant arrival times in real-time
• Provide backup transportation options if needed
• Track transportation costs and generate detailed billing reports
• Ensure participant safety through verified driver networks

Pilot Program Results

During the six-month pilot program conducted across 15 research sites, TheraNovex's ride share technology demonstrated significant improvements in trial metrics:

Safety and Compliance Features

Patient safety and regulatory compliance remain paramount in the platform's design. All rides are conducted through verified driver networks, with comprehensive background checks and vehicle inspections. The platform also maintains detailed audit trails for regulatory compliance and includes features for participants with special transportation needs, including wheelchair-accessible vehicles and medical transport options.

Availability and Implementation

The TheraNovex ride share technology platform is now available to research sites and sponsors nationwide. Implementation typically takes 2-3 weeks and includes comprehensive training for research staff, integration with existing trial management systems, and ongoing technical support.

"We're committed to removing barriers that prevent patients from accessing potentially life-changing treatments," added James Thompson, CEO of TheraNovex. "This technology represents a significant step forward in making clinical trials more accessible and inclusive for all patients."